The Microbiome Business & Science Briefing
MicrobimeTimes
Reporting on The Latest Microbiome Business & Scientific Developments
TRENDING
Microbiotica Raises $48 Million Series C to Advance Pipeline into Phase 2 Clinical Development• Prokarium: Leading the Evolution of Bacterial Immunotherapy, the Next Frontier in Cancer Treatment• Claude Discovers Novel Enzyme System with CRISPR-like Repeats• New Clinical Study Aims to Find Out if FMT capsules could help better manage anorexia• MaaT Pharma Provides Update on MaaT013 (Xervyteg®) Potential Development Plan Following CHMP Negative Opinion After Re-examination• Evvy Raises $40M Series B to Scale AI-Powered Precision Diagnostics & Care Platform for Women’s Health•

Category: Gastrointestinal

Bacteria subtype linked to growth in up to 50% of human colorectal cancers
Gastrointestinal

Bacteria subtype linked to growth in up to 50% of human colorectal cancers

MAR 26, 2024
Canada approves gut-brain axis health claims for Chr. Hansen probiotic strain
Biotics and Supplements

Canada approves gut-brain axis health claims for Chr. Hansen probiotic strain

NOV 8, 2023
First Patient Dosed in Phase 2 Clinical Trial of Vedanta’s VE202 for the Treatment of Ulcerative Colitis
Clinical & Manufacturing

First Patient Dosed in Phase 2 Clinical Trial of Vedanta’s VE202 for the Treatment of Ulcerative Colitis

OCT 5, 2023
MRM Health Reports Positive Topline Results from Phase 2a Clinical Study with MH002 in Mild-to-Moderate Ulcerative Colitis
Clinical & Manufacturing

MRM Health Reports Positive Topline Results from Phase 2a Clinical Study with MH002 in Mild-to-Moderate Ulcerative Colitis

SEP 19, 2023
Protective particles allow engineered probiotics to report gut disease
Biotics and Supplements

Protective particles allow engineered probiotics to report gut disease

SEP 12, 2023
Bactolife Raises EUR 30 million in Series A Financing
Finance

Bactolife Raises EUR 30 million in Series A Financing

AUG 8, 2023
Scientists and clinicians use AI analysis of the gut microbiome to detect colon cancer
Gastrointestinal

Scientists and clinicians use AI analysis of the gut microbiome to detect colon cancer

JUN 12, 2023
Cerebiome® exerts a positive influence on the gut microbiota of individuals with mild anxiety, new study finds
Gastrointestinal

Cerebiome® exerts a positive influence on the gut microbiota of individuals with mild anxiety, new study finds

MAY 17, 2023
Colorectal cancer surgery: Gut microbiota helps healing
Gastrointestinal

Colorectal cancer surgery: Gut microbiota helps healing

MAR 8, 2023
Phage combination therapy can precisely target IBD-related gut bacteria without harming helpful microbes
Gastrointestinal

Phage combination therapy can precisely target IBD-related gut bacteria without harming helpful microbes

AUG 23, 2022
Boehringer Ingelheim and BiomX Collaborate to Discover IBD Microbiome Biomarkers
Finance

Boehringer Ingelheim and BiomX Collaborate to Discover IBD Microbiome Biomarkers

JUL 5, 2022